Introduction
============

Long-term exposures to particulate matter (PM) and noise have both been associated with cardiovascular diseases such as ischemic heart disease and hypertension ([@r4]; [@r10]). Although particle and noise exposure frequently occur concomitantly, only a few recent epidemiologic studies have controlled for both factors ([@r7]; [@r12]; [@r18]; [@r25]).

PM-related health effects have been widely studied, and exposure to PM has been associated with cardiopulmonary diseases, which increase hospitalization and premature deaths throughout the world ([@r10]; [@r47]; [@r48]). Ultrafine particles (UFP), with diameters \< 100 nm, are considered to play an important role in triggering particle-related health effects because of their small size and large surface area. There is evidence of effects of noise on the cardiovascular system: Noise exposure in both residential and occupational settings has been associated with hypertension ([@r9]; [@r12]; [@r18]; [@r52]; [@r53]), ischemic heart disease, and myocardial infarction ([@r11]; [@r25]; [@r49]).

Road traffic is an important source of PM and noise emissions, both of which have been associated with cardiovascular effects. Alterations in heart rate variability (HRV) and vascular inflammation ([@r43]; [@r55]), as well as progression of atherosclerosis ([@r6]; [@r31]) have been attributed to traffic-related PM and at levels lower than the current annual PM~2.5~ (PM with diameter ≤ 2.5 μm) air quality standard in the United States ([@r1]). Myocardial infarction ([@r5]; [@r8]; [@r39]) and elevated cardiovascular morbidity and mortality in the general population ([@r2], [@r3]; [@r23]; [@r26]) have been associated with traffic in general, as well as with PM and/or noise emissions from traffic. Because of the simultaneous exposure it is often difficult to disentangle particle- and noise-related health effects.

We recently described how highway maintenance workers are frequently exposed to air pollutants and noise originating from road traffic and work equipment ([@r35]). Their mixed exposure to particles and noise may contribute to an increased susceptibility to the development or exacerbation of heart and vascular diseases. To investigate short-term health effects related to particles and noise, we estimated associations of exposures to PM~2.5~, UFP, and noise with various cardiopulmonary health end points. We hypothesized that particle exposure would lead to increased levels of proinflammatory and prothrombotic markers in the blood. We also expected particle- and noise-related changes in heart rate variability and an association of blood pressure elevation and noise. Because cardiovascular effects for both exposure types have been described previously, we were interested in investigating mutually adjusted health effects.

Methods
=======

*Study design*. To investigate short-term health effects of exposure to PM and noise, we carried out repeated measurements on 18 highway maintenance workers. Exposure and health assessments were conducted on 50 days between May 2010 and February 2012 in collaboration with the Swiss Road Maintenance Services on highways in western Switzerland. For work shifts of 38 days, two co-located subjects were equipped with personal measurement equipment, whereas only one subject was equipped for work shifts of 12 days. Healthy, nonsmoking male maintenance workers from 10 maintenance centers were offered participation in the study. Health criteria for exclusion were high blood pressure (systolic/diastolic \> 140/90 mmHg), cardiopulmonary health problems, acute allergies, diabetes, and obesity \[body mass index (BMI) \> 32\]. Exposure to PM~2.5~, UFP, noise, and gaseous co-pollutants was assessed during five nonconsecutive work shifts. To control for post-work-shift exposure, personal PM~2.5Realtime~ and noise exposure measurement was continued after end of work (around 1700 hours) until the next morning. PM~2.5Realtime~ measurements after work have been used only in a sensitivity analysis and not for the reported associations.

Exposure parameters were compared with HRV assessed during a sleep period approximately 10 hr after work and with further health end points that were assessed on the following morning, approximately 15 hr after work. The study was approved by the Ethics Committee from the University of Lausanne, and all research volunteers provided written informed consent.

*Exposure assessment*. The exposure assessment was presented in detail elsewhere ([@r35]). Briefly, personal real-time PM~2.5~ measurements (PM~2.5Realtime~; 1-min resolution) were made using a personal DataRam pDR1000 real-time particulate monitor (Thermo Scientific, Waltham, MA, USA) attached on the subject's back. PM~2.5~ was also measured gravimetrically (PM~2.5Mass~) at the work site using PTFE filters (\#225-1709; SKC Inc., Eighty Four, PA, USA) and a Leland Legacy sampling pump (SKC Inc.) with a flow rate of 10 L/min. UFP number concentrations and the lung-deposited surface area (LDSA; particle surface area concentration deposited in the lung) were measured at the work site using a miniDiSC ([@r17]), a method that has been shown to provide reliable results under highway conditions in the 16--300 nm size range ([@r36]). We chose LDSA as the UFP exposure metric for reporting associations with health outcomes because surface area is an important determinant for particle reactivity ([@r15]). Gaseous co-pollutants were measured at the work site: carbon monoxide (CO) with the T15n CO monitor (Langan Products, San Francisco, CA, USA); nitrogen dioxide (NO~2~) and ozone (O~3~) concentrations with diffusive samplers from Passam AG (Männedorf, Switzerland). O~3~ concentrations did not reach the detection limit (L~O3~) of 7.6 ppb for an 8-hr measurement during 22 of a total of 50 work shifts. For models including O~3~ (only in sensitivity analyses) values below the detection limit were replaced with L~O3~/2 (3.8 ppb). Temperature and humidity were measured with HOBO data loggers (U12-012; Onset Computer Corporation, Cape Cod, MA, USA). Noise was measured with personal noise dosimeters (Type 4500; Bruel & Kjaer, Nærum, Denmark) attached to the subjects. Measurements were made in the range from 70 to 140 dB(A) during work shifts and from 50 to 100 dB(A) for the continued postwork assessment until the next morning. Noise levels were corrected for periods when hearing protection was used: a 25-dB correction during use of acoustic earmuffs \[SNR (single number rating) 30\] and a 20-dB correction for preformed earplugs (SNR 25).

A detailed description about handling of missing real-time exposure data has been provided previously ([@r35]). Briefly, missing real-time particle data were replaced by estimates based on correlated particle measurements extrapolated to the distribution of the missing pollutant for the same subject, activity, and type of work site: For PM~2.5Realtime~, 0.5% missing, estimates based on parallel PM~2.5Realtime~ measurement, and, if not available, on UFP particle number concentration (PNC). For UFP, 4.8% missing, estimates based on PM~2.5Realtime~. Estimations for missing noise data (3.6%) were based on the parallel noise measurement and, if those were not available, on data from the same subject, activity, and type of work site. Missing noise data for six home-based measurements and one work-shift measurement (microphone or battery failures) could not be replaced with estimations and were not considered for analysis. Two PM~2.5Realtime~ measurements stopped early (battery failure) and did not include full duration of post-work assessment.

*Health assessment*. Before starting maintenance work and exposure assessment in the morning, the subjects were equipped with Holter H12+ Digital Recorders (Mortara Instrument, Inc., Milwaukee, WI, USA) for continuous recording of their electrocardiogram (ECG). Blood pressure, fractional exhaled nitric oxide (FeNO), and lung function were measured during a health assessment on the following morning---approximately 15 hr after work. Also, a blood sample was taken by a trained nurse for subsequent assessment of blood markers, and subjects provided information about their health status and drug intake.

Fresh blood serum and plasma samples were centrifuged and stored in a cold box at approximately 5°C until they were frozen at --80°C after a maximum of 2 hr. Frozen samples were shipped to and analyzed at the National Health and Environmental Effects Research Laboratory at the U.S. Environmental Protection Agency (Chapel Hill, NC, USA). Blood markers in serum were quantified with electrochemiluminescence detection: serum levels of interleukin 6 (IL-6) and tumor necrosis factor α (TNFα) were assessed with the Human ProInflammatory-4 II Ultra-Sensitive Kit (Meso Scale Discovery, Rockville, MD, USA). C-reactive protein (CRP) and serum amyloid A (SAA) in serum were measured using the Human Vascular Injury II Kit (Meso Scale Discovery). von Willebrand factor (vWF) was quantified in plasma with the Asserachrom® VWF:Ag ELISA kit (Diagnostica Stago, Inc., Parsippany, NJ, USA), and tissue factor (plasma) was measured with the Human Coagulation Factor III/Tissue Factor Quantikine ELISA (R&D Systems, Inc., Minneapolis, MN, USA).

ECG data were processed with H-Scribe+ software (Mortara Instrument, Inc.) and inspected manually by an experienced cardiologist (W.E.C.). Data were subsequently processed with Super ECG Software provided by David Mortara (Mortara Instrument, Inc.). Particle and noise related effects on HRV were estimated for the 5-min period between 0200 and 0400 hours when subjects were asleep and had the lowest mean heart rate. This nightly time window was chosen because it reflects a well-defined resting period when subjects were in horizontal position. The following HRV outcomes were used: standard deviation of NN intervals (SDNN), ratio of the number of pairs of adjacent NN intervals differing by \> 50 msec to the total number of NN intervals (pNN50), root mean square of the differences of successive NN intervals (RMSSD), low-frequency power (LF; 0.04--0.15 Hz), and high-frequency power (HF; 0.14--0.40 Hz). Blood pressure was measured the following morning with the automatic blood pressure monitor M10-IT (Omron Healthcare Europe, Hoofddorp, the Netherlands). The average of three successive measurements within 5 min has been used. Lung function was measured with the EasyOne Worldspirometer (NDD Medizintechnik, Zurich, Switzerland) in the "FVC \[forced vital capacity\] expiratory" test mode; test procedure was according to American Thoracic Society standards for forced expiratory volume in 1 sec (FEV~1~) and FVC test procedure ([@r37]). Expiratory air for FeNO analysis was collected with an offline collection kit (ECO MEDICS AG, Duernten, Switzerland) ([@r46]). Samples were taken in triplicate and analyzed within 6 hr of sampling. Analysis was performed with the EcoMedics CDL-88-Analyzer.

*Statistical analysis*. Health end points were compared with particle and noise exposure averaged over the preceding work shift and noise exposure during the time period after work. Linear mixed-effects regression models with subject-specific random intercepts were used to estimate exposure-related health effects clustered in individuals. We estimated mutually adjusted associations of particles and noise exposures by including both parameters in the same models. Separate models were used for particle exposure metrics: PM~2.5Realtime~ and PM~2.5Mass~ (10-μg/m^3^ increase), UFP PNC (10,000-particles/cm^3^ increase), UFP LDSA (10-μm^2^/cm^3^ increase); each model also included separate continuous variables for noise at work and noise after work, with associations estimated for a 1-dB(A) increase in each noise exposure metric. All models were adjusted for age and BMI as continuous variables. Confounding of other untransformed continuous covariates (temperature, humidity, NO~2~, O~3~, CO) was assessed by sensitivity analyses in which models were adjusted for these variables. All HRV outcomes other than pNN50 and the IL-6, CRP, and SAA blood markers were normalized by natural log-transformation. We used a *p*-value \< 0.05 to define statistical significance. All statistical models were calculated using STATA release 12 (StataCorp LP, College Station, TX, USA).

Results
=======

For the analysis of short-term health effects of particle and noise exposure we used data from repeated measurements on 18 healthy non-smoking male highway maintenance workers. Subjects participated in five repeated measurements (one subject only in three repetitions). Subjects were between 31 and 59 years old (mean, 46 years). Their weights ranged from 78 to 107 kg (mean, 82.4 kg) and their heights from 165 to 187 cm (mean, 175 cm), with BMIs between 21.8 and 31.1 kg/m^2^ (mean, 26.7 kg/m^2^). Two of the subjects were being treated with ACE (angiotensin-converting-enzyme) inhibitor for high blood pressure; one subject took a low-dose aspirin daily. A sensitivity analysis excluding these subjects did not change associations with the investigated health end points. Three measurements were excluded post hoc because subjects did not meet the inclusion criteria of being healthy (reported cold symptoms, cold medication, CRP levels \> 15 mg/L). One particular work shift during which two measurements were conducted was excluded because particle exposure was very high (PM~2.5Realtime~ \> 500 μg/m^3^; PM~2.5Mass~ \> 300 μg/m^3^; LDSA \> 600 μm^2^/cm^3^) and did not represent a standard exposure (\> 4 × SD higher than the mean). The following health data were missing: HRV data of five measurements (memory card or battery failure; one with bad ECG signal), blood data of six measurements (subjects refused blood withdrawal), and a plasma sample for vWF and tissue factor analysis of one measurement (lost during analysis). A total of 77 observations for which particle and noise exposure as well as health parameters were available were used for blood pressure models, 73 observations for HRV models, and 71 observations for blood marker models (70 for vWF and tissue factor).

Summary statistics with the exposure averages used to assess associations with health outcomes are shown in [Table 1](#t1){ref-type="table"}. As a consequence of the varied work activities, we observed a high variability in particle and noise exposure. Particle concentrations and noise levels were highest for work shifts that included the use of specific working equipment (hand-held string trimmers, chain saws, pneumatic hammers). PM~2.5~ levels after work were considerably lower than during work, and their contribution to the total particle dose was minor. Noise measurements after work were characterized by noise levels in the early evening; nighttime noise rarely reached the lower measurement limit of 50 dB(A). Spearman correlations of particles and noise during work were low (ρ \~ 0.3 for PM~2.5~ and noise) to moderate (ρ = 0.5 for PNC and noise). LDSA, a measure of exposure to UFP, was highly correlated to the UFP particle number concentration (PNC) (Pearson correlation *r* = 0.96). A more detailed description of exposure to air pollutants and noise during highway maintenance work has been described previously ([@r35]). The slight differences between the means reported in [Table 1](#t1){ref-type="table"} and the means reported in our previous publication are attributable to excluded observations because of missing or invalid health data.

###### 

Summary statistics of exposure parameters used to assess associations between exposure and health outcomes.

  Exposure                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      Mean ± SD         Minimum   Maximum   No. of observations^*a*^
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------- --------- --------- --------------------------
  PM~2.5Realtime~ work (μg/m^3^)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                65.7 ± 69.9       7.3       347.8     77
  PM~2.5Realtime~ after work (μg/m^3^)^*b*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     22.9 ± 19.5       0.2       81.3      75
  PM~2.5Mass~ work (μg/m^3^)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    56.1 ± 39.0       20.3      186.9     48
  UFP PNC work (particles/cm^3^)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                75,699 ± 81,761   15,524    331,683   48
  UFP LDSA work (μm^2^/cm^3^)^*c*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              111.6 ± 86.8      31.5      385.5     48
  *L*~eq~ work (dB\[A\])^*d*^                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   81.0 ± 3.6        73.3      91.6      77
  *L*~eq~ after work (dB\[A\])                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  65.8 ± 5.8        56.4      85.0      77
  *L*~eq~, equivalent continuous noise level. ^***a***^Number of total personal exposure assessments (PM~2.5Realtime~ and *L*~eq~) and total exposure assessment at work site (PM~2.5Mass~, UFP PNC, and UFP LDSA). Exposure measured at work site was assigned to two subjects when two co-located subjects were measured during the same work shift. Due to missing health data, not all observations were used in all models: a total of 77 observations were used for blood pressure models, 73 observations for HRV models, and 71 observations for blood marker models. ^***b***^PM~2.5Realtime~ measurements after work have only been used in sensitivity analyses and not for the reported associations. ^***c***^Lung-deposited surface area of ultrafine particles. ^***d***^*L*~eq~ over full work shift corrected for the use of ear protection.                                         

All health parameters were within a normal range; summary statistics of health end points are provided in [Table 2](#t2){ref-type="table"}. Coefficients of mixed-effects regression models used to estimate associations between particles and blood markers (with adjustment for work and after work noise) are shown in [Table 3](#t3){ref-type="table"}. PM~2.5Mass~ was significantly and positively associated with CRP and SAA concentrations \[percent increases associated with a 10-μg/m^3^ increase in exposure of 5.56% (95% CI: 1.05, 10.27%) and 3.56% (95% CI: 0.04, 7.21%), respectively\] and negatively associated with TNFα (--0.60%; 95% CI: --1.15, --0.04%). None of the proinflammatory or prothrombotic markers were significantly associated with UFP LDSA ([Table 3](#t3){ref-type="table"}) or PNC (data not shown). Work noise was not significantly associated with any of the blood markers (*p* \> 0.3), and associations with particle exposures did not change when models were not adjusted for work or after work noise (data not shown). Noise after work was significantly associated with vWF (increase of 1.48%; 95% CI: 0.40, 2.56% per 1 dB; model adjusted for PM~2.5Realtime~ and work noise) but not any of the other blood markers (data not shown).

###### 

Summary statistics of health end points used to assess associations between exposure and health outcomes.

  Outcome                                                                                                                                                                                        Mean ± SD        Minimum   Maximum   No. of observations
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------- --------- --------- ---------------------
  Blood pressure (mmHg)                                                                                                                                                                                                               
  Systolic                                                                                                                                                                                       122.2 ± 13.4     95.0      154.0     77
  Diastolic                                                                                                                                                                                      78.1 ± 8.6       62.0      102.0     77
  Proinflammatory and prothrombotic blood markers                                                                                                                                                                                     
  Serum IL-6 (ng/L)                                                                                                                                                                              0.54 ± 0.29      0.17      1.46      71
  Serum TNFα (ng/L)                                                                                                                                                                              3.79 ± 1.00      1.16      6.52      71
  Serum CRP (mg/L)                                                                                                                                                                               2.09 ± 1.64      0.19      7.24      71
  Serum SAA (mg/L)                                                                                                                                                                               4.63 ± 4.01      0.85      17.53     71
  Plasma vWF (%)                                                                                                                                                                                 109.22 ± 39.57   37.40     207.00    70
  Plasma tissue factor (ng/L)                                                                                                                                                                    74.84 ± 29.77    30.90     177.90    70
  HRV parameters                                                                                                                                                                                                                      
  Mean HR (beats/min)                                                                                                                                                                            54.4 ± 7.7       42.0      79.0      73
  SDNN (msec)                                                                                                                                                                                    82.7 ± 46.9      25.0      226.0     73
  pNN50 (%)                                                                                                                                                                                      28.7 ± 24.8      0.0       87.0      73
  RMSSD (msec)                                                                                                                                                                                   73.8 ± 66.1      8.0       279.0     73
  High frequency power (msec^2^)                                                                                                                                                                 3,325 ± 6,261    23        32,544    73
  Low frequency power (msec^2^)                                                                                                                                                                  3,041 ± 2,921    220       14,790    73
  Ratio HF/LF                                                                                                                                                                                    2.9 ± 2.5        0.2       11.3      73
  Lung parameters                                                                                                                                                                                                                     
  FeNO (ppb)                                                                                                                                                                                     18.6 ± 6.3       7.4       38.7      77
  FVC (L)                                                                                                                                                                                        4.8 ± 0.5        3.7       6.1       77
  FEV~1~ (L)                                                                                                                                                                                     3.8 ± 0.4        2.8       4.7       77
  Blood pressure, blood markers, and lung parameters were assessed in the morning after the day of exposure assessment. HRV was assessed during a sleep period approximately 10 hr after work.                                        

###### 

Associations of particle exposures during work and proinflammatory and prothrombotic markers in the blood \[percent differences (95% CI)\].^*a*^

  Outcome                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   PM~2.5Realtime~         PM~2.5Mass~               LDSA
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------- ------------------------- -----------------------
  IL-6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      --1.18 (--2.60, 0.26)   --1.52 (--3.98, 1.00)     --0.65 (--1.98, 0.70)
  TNFα                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      --0.25 (--0.58, 0.08)   --0.60 (--1.15, --0.04)   0.02 (--0.31, 0.35)
  CRP                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1.97 (--0.62, 4.62)     5.56 (1.05, 10.27)        1.38 (--0.88, 3.70)
  SAA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       1.23 (--0.79, 3.29)     3.56 (0.04, 7.21)         1.00 (--0.88, 2.91)
  vWF                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       0.30 (--0.55, 1.15)     0.41 (--1.06, 1.88)       0.17 (--0.66, 0.99)
  Tissue factor                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             --0.96 (--2.24, 0.32)   --0.56 (--2.80, 1.69)     --0.84 (--2.05, 0.37)
  LDSA, lung-deposited surface area of UFP. ^***a***^Estimates from linear mixed-effects regression models with subject-specific random intercepts to account for repeated observations. All models were adjusted for noise exposure at work, noise exposure after work, age, and BMI. Point estimates represent estimated percent changes in natural log (ln)--transformed outcomes with a 10-μg/m^3^ increase in PM~2.5Realtime~ and PM~2.5Mass~, and a 10-μm^2^/cm^3^ increase in LDSA. Percent changes of TNFα, vWF, and tissue factor, which have not been ln-transformed, were calculated in reference to the mean.                                                     

In general, 10-μg/m^3^ increases in both PM~2.5~ exposure metrics, and a 1 dB(A) increase in noise at work, were associated with increased HRV, as indicated by positive associations with SDNN, pNN50, and RMSSD ([Figure 1](#f1){ref-type="fig"}). In contrast, a 1-dB(A) increase in noise after work was associated with nonsignificant decreases in HRV. PM~2.5~ exposures and noise at work were significantly associated with HF and also positively associated with LF, with no association with the LF/HF ratio. Noise after work was associated with nonsignificant decreases in HF and increases in the LF/HF ratio. Patterns of associations were similar for UFP LDSA, though point estimates were closer to the null. Associations were comparable for particle exposures based on models that were not adjusted for noise, and for noise exposures based on models that were not adjusted for particles (data not shown). Associations with UFP PNC (data not shown) were similar to those for UFP LDSA.

![Mutually adjusted associations of particle exposures for PM~2.5Realtime~ (*A*), PM~2.5Mass~(*B*), and UFP LDSA (*C*), noise exposure during work, and noise exposure after work with HRV (measured during a sleep period approximately 10 hr after work). Estimates were from linear mixed-effects regression models with subject-specific random intercepts to account for repeated observations. All models have been adjusted for age and BMI. Percent change of pNN50, which has not been ln-transformed, was calculated in reference to the mean.](ehp.1307100.g001){#f1}

PM~2.5~, UFP LDSA, and noise after work were positively associated with systolic and diastolic blood pressure the next morning, whereas work noise showed nonsignificant negative associations with blood pressure ([Figure 2](#f2){ref-type="fig"}). Effect estimates were similar for particles without adjustment for noise, and for noise without adjustment for particles (data not shown). However, LDSA was no longer significantly associated with systolic blood pressure when modeled without adjustment for noise (data not shown).

![Mutually adjusted associations of particle exposures for PM~2.5Realtime~ (*A*), PM~2.5Mass~(*B*), and UFP LDSA (*C*), noise exposure during work, and noise exposure after work with systolic and diastolic blood pressure measured in the morning approximately 15 hr after work. Estimates were from linear mixed-effects regression models with subject-specific random intercepts to account for repeated observations. All models have been adjusted for age and BMI. Percent changes were calculated in reference to the mean blood pressure.](ehp.1307100.g002){#f2}

None of the particle exposure metrics were significantly associated with lung function measures (FEV~1~ and FVC) or FeNO (data not shown). We did not estimate associations between noise and lung function.

In a series of sensitivity analyses, we observed that adjusting our models for temperature, humidity, NO~2~, O~3~, or CO did not result in a change in estimated associations between the health outcomes and particles or noise. Associations between co-pollutants and health outcomes were not significant (data not shown). However, associations with all particle metrics were close to the null for all inflammation markers and HRV parameters when two outlier observations with very high particle levels (PM~2.5Realtime~ \> 500 μg/m^3^; PM~2.5Mass~ \> 300 μg/m^3^; LDSA \> 600 μm^2^/cm^3^) were included in the models (data not shown). The origin of these high particle levels is uncertain, but may be related to hot and dry conditions causing elevated dispersion of soil dust during mowing. Furthermore we could see that considering personal PM~2.5Realtime~ averaged over work shift and time at home, instead of considering work shift PM~2.5Realtime~ levels, did not change the findings for PM~2.5Realtime~ (data not shown). Omitting correction of work noise for the use of ear protection resulted in smaller, less significant effect estimates of work noise on HRV (no changes in effect estimates for particles and noise after work) (data not shown). Estimates for blood pressure with/without ear protection were far from significance in either case.

Discussion
==========

In this study we investigated associations of short-term particle and noise exposures during highway maintenance work with markers of cardiovascular and pulmonary health. Repeated measurements---including the assessment of the particle and noise exposure, as well as selected health end points---were conducted on a sample of 18 healthy, nonsmoking male maintenance workers. PM~2.5~ exposures were positively associated with acute-phase inflammation markers in the blood, and particle and noise exposures at work were associated with higher HRV. Elevated noise exposure during recreational time after work was associated with higher systolic and diastolic blood pressure. We did not observe any evidence of short-term effects of particle exposures on lung function or nitric oxide concentrations in exhaled air.

The positive association of PM~2.5~ with CRP and SAA, two inflammation markers that have been related to arteriosclerosis and other cardiovascular diseases ([@r28]; [@r42]), is consistent with previous reports of associations between air pollution and traffic exposure with acute-phase inflammation ([@r38]; [@r43]; [@r44]). Contrary to our expectations, PM~2.5~ exposure was negatively associated with TNFα and IL-6 concentrations (statistically significant for TNFα). This may be a matter of timing. It has been shown that the TNFα and IL-6 response in rats exposed to diesel did not occur until 24--48 hr after exposure ([@r29]). However, the observed negative associations may have been caused by chance or systematic error.

Particle exposures and work noise were both associated with higher HRV during the recovery period in the night. The nightly time window was chosen because it reflects a well-defined resting period when subjects were in horizontal position. Interestingly, particle and work noise were associated with higher HRV independent of each other, based on mutually adjusted models. The increase in high-frequency power and RMSSD suggests changes in vagal activity, which is a major contributor of the HF component ([@r34]). However, we have seen positive associations with HF and LF power resulting in null associations with the LF/HF ratio. Hence, a reciprocal relationship between sympathetic and parasympathetic balance does not appear to be present under the present conditions similar to the positive associations between ultrafine concentrated ambient particles and HF and LF power reported by a recent study ([@r45]). Others reported increased vagal activity after exposure to fine particles, characterized by increased RMSSD and decreased SDANN ([@r41]) and increased HF variability and decreased LF/HF ratio ([@r43]). However, particle exposures have often been associated with lower HRV ([@r20]; [@r21]; [@r22]; [@r24]; [@r32]; [@r33]; [@r40]; [@r54]), and some studies reported evidence of variable effects depending on subjects or particle sizes ([@r13]; [@r50]; [@r56]). Associations of particle exposures and HRV may be influenced by age, cardiovascular health history, or genetic background, as well as the duration of exposure, timing of the clinical evaluation, and the composition and size of particles. However, there is no clear pattern across these studies that can explain the contradictory results. Timing may have played an important role in regard to the associations between work noise, noise after work, and HRV. A recent study describing immediate changes in HRV changes after noise exposure showed that SDNN was positively associated with concurrent noise \> 65 dB(A), but negatively to noise exposure lagged by 5--15 min ([@r30]).

Noise exposure after work was significantly associated with higher blood pressure measured on the following morning. Work noise was associated with lower blood pressure, though associations were imprecise and not statistically significant. As for HRV, it is important to consider the time lag of these outcomes. The time point of evaluation may not reflect acute effects of noise exposure of the day before. A few recent studies have reported associations between occupational noise exposure and blood pressure and cardiovascular diseases, although their results are contradictory ([@r19]; [@r51]; [@r53]). However, associations of noise and cardiovascular health outcomes were more commonly linked to traffic and aircraft noise at home and during recreational periods outside occupational settings ([@r4]; [@r14]; [@r16]; [@r27]). The type of noise sources affects noise perception and seems to be an important determinant for noise specific health effects ([@r4]). Work noise was primarily dominated by working equipment and secondly by road traffic. We do not have information about the type of noise sources for the period after work. After-work noise was characterized by events in the early evening and might have been strongly influenced by noise caused by the subjects themselves (e.g., hobby, music, televison). However, we cannot differentiate it from environmental noise, and we cannot exclude that disturbing night noise below the lower measurement limit of 50 dB(A) confounded associations with health outcomes. Changes in effect estimates by omitting correction of work noise for ear protection show that controlling for this is important.

The similar effect estimates of particle exposure models adjusted for noise and of noise exposure models adjusted for particles are in line with recent publications that did not see changes when controlling for both factors. Noise did not change effect estimates for an elevated risk for high blood pressure and cardiovascular mortality attributed to PM~2.5~, black smoke, and traffic intensity ([@r7]; [@r18]). Associations between aircraft noise and death from myocardial infarction were not attenuated by adjusting for PM~10~ (PM with diameter ≤ 10 μm) ([@r25]). Risk estimates for hypertension in relation to traffic noise did not change significantly when adjusted for PM~10~ ([@r12]). However, a recent study investigating combined effects on HRV reported stronger associations between traffic related air pollution and HRV when noise levels were \> 65.6 dB(A) ([@r24]).

Conclusions
===========

In this study we observed higher acute-phase inflammation markers CRP and SAA as well as a decrease in TNFα in association with PM~2.5~. PM~2.5~ and work noise were independently associated with higher HRV during the night after a work shift. Noise levels during recreational time after work were positively associated with blood pressure measurements taken the following morning. Our findings suggest that exposure to particles and noise at the workplace might pose a cardiovascular health risk, as evidenced by associated increases in proinflammatory biomarkers. It is therefore important to make efforts to reduce these exposures.
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